HIF1A and cancer: Consistent with the differences in metabolite levels, the expression of corresponding lipid metabolism- and glycan biosynthesis-associated genes was increased in lipomet-PDAC, and the expression of genes associated with glucose metabolism (the hypoxia inducible factor-1 [HIF-1] signaling pathway and central carbon metabolism in cancer) were increased in glucomet-PDAC (Figure 1P).